Carrier Design: Biodistribution of Branched Polypeptides with a Poly(L-lysine) Backbone

被引:27
作者
Clegg, J. A. [1 ]
Hudecz, F. [2 ]
Mezoe, G. [2 ]
Pimm, M. V. [1 ]
Szekerke, M. [2 ]
Baldwin, R. W. [1 ]
机构
[1] Univ Nottingham, Canc Res Campaign Labs, Nottingham NG7 2RD, England
[2] Eotvos Lorand Univ, Hungarian Acad Sci, Res Grp Peptide Chem, H-1518 Budapest 112, Hungary
关键词
D O I
10.1021/bc00006a009
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The biodistribution has been examined in mice of a range of synthetic branched polypeptides which are based on a polylysine backbone but which differ in ionic charge, side-chain structure, and molecular size. Polycationic polypeptides, regardless of their size or primary structure at the branches, were cleared rapidly from the circulation, the liver being the major site of clearance. Polypeptides with glutamic acid in the side chain, which would be amphoteric under physiological conditions, showed a significantly prolonged blood survival, and this was seen with polypeptides in the range of molecular weights of 46 000 up to 213 000. Such polypeptides provide a useful system with which to investigate the effect of structural parameters on the pharmacokinetic properties of carrier molecules and would allow the selection of candidate carriers for a variety of uses.
引用
收藏
页码:425 / 430
页数:6
相关论文
共 29 条
[1]   SUCCESSFUL IMMUNIZATION WITH A TOTALLY SYNTHETIC DIPHTHERIA VACCINE [J].
AUDIBERT, F ;
JOLIVET, M ;
CHEDID, L ;
ARNON, R ;
SELA, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1982, 79 (16) :5042-5046
[2]   MONOCLONAL-ANTIBODIES AGAINST DOXORUBICIN [J].
BALSARI, A ;
ALZANI, R ;
PARRELLO, D ;
MORELLI, D ;
TAGLIABUE, E ;
GIANNI, L ;
ISETTA, AM ;
MENARD, S ;
COLNAGHI, MI ;
GHIONE, M .
INTERNATIONAL JOURNAL OF CANCER, 1988, 42 (05) :798-802
[3]   LABELING OF PROTEINS TO HIGH SPECIFIC RADIOACTIVITIES BY CONJUGATION TO A I-125-CONTAINING ACYLATING AGENT - APPLICATION TO RADIOIMMUNOASSAY [J].
BOLTON, AE ;
HUNTER, WM .
BIOCHEMICAL JOURNAL, 1973, 133 (03) :529-538
[4]   MURAMYL DIPEPTIDE BOUND TO POLY-L-LYSINE SUBSTITUTED WITH MANNOSE AND GLUCONOYL RESIDUES AS MACROPHAGE ACTIVATORS [J].
DERRIEN, D ;
MIDOUX, P ;
PETIT, C ;
NEGRE, E ;
MAYER, R ;
MONSIGNY, M ;
ROCHE, AC .
GLYCOCONJUGATE JOURNAL, 1989, 6 (02) :241-255
[5]   PEPTIDES AND PROTEINS AS DRUGS [J].
FERRAIOLO, BL ;
BENET, LZ .
PHARMACEUTICAL RESEARCH, 1985, (04) :151-156
[6]  
GAAL D, 1986, J BIOL RESP MODIF, V5, P148
[7]  
GHOSE T, 1986, CRC CRIT R THER DRUG, V3, P263
[8]   INFLUENCE OF SIDE-CHAIN-TERMINATING MOIETIES ON THE CONFORMATION OF BRANCHED POLYPEPTIDES AND THEIR CONJUGATES WITH 4-ETHOXYMETHYLENE-2-PHENYL-5(4H)-OXAZOLONE [J].
HUDECZ, F ;
KAJTAR, J ;
SZEKERKE, M .
BIOPHYSICAL CHEMISTRY, 1988, 31 (1-2) :53-61
[9]   BIODEGRADABILITY OF SYNTHETIC BRANCHED POLYPEPTIDE WITH POLY(L-LYSINE) BACKBONE [J].
HUDECZ, F ;
KUTASSIKOVACS, S ;
MEZO, G ;
SZEKERKE, M .
BIOLOGICAL CHEMISTRY HOPPE-SEYLER, 1989, 370 (09) :1019-1026